We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Inflammatory Molecules Increased in ALS

By LabMedica International staff writers
Posted on 06 Sep 2017
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a fatal neurodegenerative disease characterized by the degeneration of motor neurons in brain and spinal cord. More...
Only 5% to 10% of ALS cases are explained by a genetic mutation, while 90% to 95% of cases are sporadic, with no known cause.

A growing number of studies indicate that inflammation in the central nervous system is a key factor in ALS and additionally, increased levels of immune cells that trigger inflammatory responses have been found in the central nervous system of ALS patients. Clinical studies indicated that peripheral inflammation is involved in ALS, where markers of inflammation such as T-cells, cytokines, and chemokines were found.

Scientists at Minzu University of China (Beijing, China) performed a systematic review and meta-analysis that identified 25 studies, including 812 ALS patients and 639 controls. This was done in order to address inconsistent results, so they compared levels of inflammatory cytokines between ALS patients and controls. The clinical data information was then combined and analyzed.

The meta-analysis found significant heterogeneity for eight of 14 cytokines. Interleukin (IL)-2, IL-4, IL-17, vascular endothelial growth factor (VEGF) showed moderate levels of heterogeneity, whereas tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1), interferon gamma (IFNγ), IL-5 showed high levels of heterogeneity. Sub-group analyses revealed that blood TNF-α levels were significantly increased in ALS patients compared with normal control subjects.

The scientists noted that previous data demonstrated that blood levels of TNF-α, IL-6 and IL-1β were elevated in patients with Alzheimer’s disease and Parkinson’s disease, while Tumor necrosis factor receptor 1(TNFR1) was augmented in Parkinson’s disease, suggesting a common mechanism in different neurodegenerative disorders.

The authors concluded that, their meta-analysis is the first undertaken to investigate the alterations of inflammatory cytokine levels in ALS patients, and demonstrated increased peripheral blood TNF-α, TNFR1, IL-1β, IL-6, IL-8 and VEGF levels in ALS patients compared to control subjects. The study highlights the possibility that peripheral levels of cytokines could be biomarkers for ALS, which would offer an attractive approach for medical professionals seeking to bridge the gap between diagnosis and onset of symptoms. The study was published on August 22, 2017, in the journal Scientific Reports.

Related Links:
Minzu University of China


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.